Roche shares drop after deaths of patients taking Hemlibra
Roche shares drop after deaths of patients taking Hemlibra ZURICH (Reuters) – Swiss drugmaker Roche’s shares dropped on Wednesday after it told U.S.-based haemophilia advocacy groups that five patients treated with its medicine Hemlibra had died, while maintaining that the therapy was not the cause of the deaths. The shares slipped 2 percent by 0850 GMT — double the […]
Read more